Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism
- PMID: 38474620
- PMCID: PMC10934602
- DOI: 10.3390/molecules29051108
Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism
Abstract
Hyperlipidemia, characterized by elevated serum lipid concentrations resulting from lipid metabolism dysfunction, represents a prevalent global health concern. Ginsenoside Rb1, compound K (CK), and 20(S)-protopanaxadiol (PPD), bioactive constituents derived from Panax ginseng, have shown promise in mitigating lipid metabolism disorders. However, the comparative efficacy and underlying mechanisms of these compounds in hyperlipidemia prevention remain inadequately explored. This study investigates the impact of ginsenoside Rb1, CK, and PPD supplementation on hyperlipidemia in rats induced by a high-fat diet. Our findings demonstrate that ginsenoside Rb1 significantly decreased body weight and body weight gain, ameliorated hepatic steatosis, and improved dyslipidemia in HFD-fed rats, outperforming CK and PPD. Moreover, ginsenoside Rb1, CK, and PPD distinctly modified gut microbiota composition and function. Ginsenoside Rb1 increased the relative abundance of Blautia and Eubacterium, while PPD elevated Akkermansia levels. Both CK and PPD increased Prevotella and Bacteroides, whereas Clostridium-sensu-stricto and Lactobacillus were reduced following treatment with all three compounds. Notably, only ginsenoside Rb1 enhanced lipid metabolism by modulating the PPARγ/ACC/FAS signaling pathway and promoting fatty acid β-oxidation. Additionally, all three ginsenosides markedly improved bile acid enterohepatic circulation via the FXR/CYP7A1 pathway, reducing hepatic and serum total bile acids and modulating bile acid pool composition by decreasing primary/unconjugated bile acids (CA, CDCA, and β-MCA) and increasing conjugated bile acids (TCDCA, GCDCA, GDCA, and TUDCA), correlated with gut microbiota changes. In conclusion, our results suggest that ginsenoside Rb1, CK, and PPD supplementation offer promising prebiotic interventions for managing HFD-induced hyperlipidemia in rats, with ginsenoside Rb1 demonstrating superior efficacy.
Keywords: bile acid metabolism; ginsenoside CK; ginsenoside PPD; ginsenoside Rb1; gut microbiota; hyperlipidemia.
Conflict of interest statement
There are no conflicts of interest to declare.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-g002.gif)
![formula image](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-i001.jpg)
![formula image](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-i002.jpg)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10934602/bin/molecules-29-01108-g006.gif)
Similar articles
-
Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.J Ethnopharmacol. 2018 Apr 24;216:47-56. doi: 10.1016/j.jep.2018.01.021. Epub 2018 Jan 31. J Ethnopharmacol. 2018. PMID: 29366768
-
Ginsenosides retard atherogenesis via remodelling host-microbiome metabolic homeostasis.Br J Pharmacol. 2024 Jun;181(12):1768-1792. doi: 10.1111/bph.16320. Epub 2024 Feb 14. Br J Pharmacol. 2024. PMID: 38355288
-
Bacteroides vulgatus Ameliorates Lipid Metabolic Disorders and Modulates Gut Microbial Composition in Hyperlipidemic Rats.Microbiol Spectr. 2023 Feb 14;11(1):e0251722. doi: 10.1128/spectrum.02517-22. Epub 2023 Jan 10. Microbiol Spectr. 2023. PMID: 36625637 Free PMC article.
-
[Protopanaxadiol-type ginsenoside hydrolases and their application in the preparation of ginsenoside Compound K: a review].Sheng Wu Gong Cheng Xue Bao. 2023 Mar 25;39(3):978-992. doi: 10.13345/j.cjb.220492. Sheng Wu Gong Cheng Xue Bao. 2023. PMID: 36994566 Review. Chinese.
-
Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities.Drug Metab Rev. 2020 Feb;52(1):125-138. doi: 10.1080/03602532.2020.1714645. Epub 2020 Jan 26. Drug Metab Rev. 2020. PMID: 31984805 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous